表紙
市場調査レポート

ライブセルイメージングの世界市場分析・予測 2019年:FRAP・HCS

Live Cell Imaging Market by Product (Equipment, Consumables, Software), Technology (Fluorescence Recovery after Photobleaching, High-Content Screening) & by Application (Cell Biology, Stem Cells, Drug Discovery) - Analysis & Global Forecast to 2019

発行 MarketsandMarkets 商品コード 330389
出版日 ページ情報 英文 193 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.85円で換算しております。
Back to Top
ライブセルイメージングの世界市場分析・予測 2019年:FRAP・HCS Live Cell Imaging Market by Product (Equipment, Consumables, Software), Technology (Fluorescence Recovery after Photobleaching, High-Content Screening) & by Application (Cell Biology, Stem Cells, Drug Discovery) - Analysis & Global Forecast to 2019
出版日: 2015年05月12日 ページ情報: 英文 193 Pages
概要

世界のライブセルイメージング市場規模は、予測期間中に8.8%のCAGRで成長すると見込まれています。創薬におけるハイコンテントスクリーニング技術の導入、世界的な癌発症率の増加、およびセルベース研究における政府の財政援助といった要因が、同市場の成長を促進しています。さらに、新興アジア市場におけるプライマリースクリーニング向け廃コンテントスクリーニングの導入、およびオーダーメイド医療におけるライブセルイメージング技術用途の増加も、今後数年間のライブセルイメージング市場へ大きなチャンスを生み出すと見込まれています。しかし、ハイコンテントスクリーニングシステムの高コスト、および知識が豊富な・熟練した専門家の不足が、同市場の成長を抑制しています。

当レポートでは、世界のライブセルイメージング市場について調査し、市場概要と産業構造、製品・技術・用途・地域別の市場分析および市場成長予測、市場成長への各種影響因子と市場機会の分析、地域および主要国別の動向、競合環境と市場シェア、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 世界のライブセルイメージング市場規模
  • 世界のライブセルイメージング市場:製品別
  • ライブセルイメージング市場:用途・地域別
  • ライブセルイメージング顕微鏡市場:種類別
  • 地域別のスナップショット

第5章 市場概要

  • イントロダクション
  • 市場区分
  • 市場ダイナミクス
    • 成長推進因子
    • 成長阻害因子
    • 機会
    • 課題

第6章 産業動向

  • エンドユーザー市場の可能性分析
    • 大学・政府機関
    • 医薬品・バイオテクノロジー企業
    • 開発業務受託機関 (CRO)
    • 診断ラボ
  • サプライチェーン分析
    • 有望企業
    • 中小企業
    • エンドユーザー
    • 主な影響因子

第7章 市場潜在性分析

  • イントロダクション
  • アンメットニーズ/制限要因
  • ライブセルイメージング技術の導入を促進するための必要条件

第8章 ライブセルイメージング市場:製品別

  • イントロダクション
  • 装置
    • 独立型システム
    • 顕微鏡
    • セルアナライザー
    • イメージキャプチャーデバイス
  • 消耗品
    • アッセイキット
    • 試薬
    • 媒体
    • その他の消耗品
  • ソフトウェア

第9章 ライブセルイメージング市場:技術別

  • イントロダクション
  • 蛍光共鳴エネルギー移動 (FRET)
  • 光in situハイブリダイゼーション (FISH)
  • ハイコンテントスクリーニング (HCS)
  • 蛍光退色後回復測定 (FRAP)
  • レシオメトリックイメージング
  • 全反射照明蛍光顕微鏡 (TIRF)
  • 多光子励起顕微鏡 (MPE)
  • その他の技術

第10章 ライブセルイメージング市場:用途別

  • イントロダクション
  • 細胞生物学
  • 幹細胞
  • 発生生物学
  • 創薬

第11章 ライブセルイメージング市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア

第12章 競合環境

  • 市場シェア分析
  • 競合状況・動向

第13章 企業プロファイル

  • イントロダクション
  • Becton, Dickinson and Company
  • Carl Zeiss AG
  • Danaher Corporation (Leica Microsystems)
  • GE Healthcare (General Electric Company の子会社)
  • Molecular Devices, LLC
  • ニコン
  • オリンパス
  • Perkinelmer, Inc.
  • Sigma-Aldrich Corporation
  • Thermo Fisher Scientific, Inc.

第14章 付録

図表リスト

目次
Product Code: BT 3390

Over the years, the live cell imaging market has witnessed various technological advancements in order to study the functions of live cells that meet the needs of academic and government institutes, pharmaceutical and biotechnology industries, contract research organizations, and diagnostics laboratories. These advancements have led to the development of various technologies used for live cell imaging.

In 2014, the equipment segment accounted for the largest share of the live cell imaging market, by product; the microscopy segment accounted for the largest share of the live cell imaging market, by equipment; the assay kits segment accounted for the largest share of the live cell imaging market, by consumables; the fluorescence resonance energy transfer (FRET) segment accounted for the largest share of the live cell imaging market, by technology; and the cell biology segment accounted for the largest share of live cell imaging market, by application.

In 2014, North America accounted for the largest share of the live cell imaging market, followed by Europe, Asia, and the Rest of the World (RoW). In the coming years, the live cell imaging market is expected to witness the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to increase revenues for the manufacturers of equipment, consumables, and software involved in live cell imaging.

The global live cell imaging market witnesses high-competitive intensity as there are several big and many small firms with similar product offerings. These companies adopt various strategies (agreements, partnerships, joint ventures, collaborations, geographical expansions, and acquisitions) to increase their market shares and to establish a strong foothold in the global market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the live cell imaging market. The report analyzes the live cell imaging market by product, technology, and application
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the live cell imaging market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various live cell imaging technologies across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the live cell imaging market
  • Competitive Assessment: In-depth assessment of the market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the live cell imaging market

Table of Contents

1. Introduction

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Scope
  • 1.4. Markets Covered
  • 1.5. Years Considered for the Study
  • 1.6. Currency
  • 1.7. Limitations
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Secondary and Primary Research Methodology
    • 2.1.1. Secondary Research
      • 2.1.1.1. Key Data From Secondary Sources
    • 2.1.2. Primary Research
    • 2.1.3. Key Industry Insights
      • 2.1.3.1. Key Data From Primary Sources
      • 2.1.3.2. Key Insights From Primary Sources
  • 2.2. Market Size Estimation Methodology
  • 2.3. Market Forecast Methodology
  • 2.4. Market Data Validation and Data Triangulation
  • 2.5. Assumptions

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Live Cell Imaging Market, By Product
    • 3.2.2. Live Cell Imaging Instruments Market, By Type
    • 3.2.3. Live Cell Imaging Microscopy Market, By Type
    • 3.2.4. Live Cell Imaging Consumables Market, By Type
    • 3.2.5. Live Cell Imaging Market, By Technology
    • 3.2.6. Live Cell Imaging Market, By Application
    • 3.2.7. Live Cell Imaging Market, By Region
  • 3.3. Market Share
  • 3.4. Competitive Landscape
  • 3.5. Key Players

4. Premium Insights

  • 4.1. Global Live Cell Imaging Market Size
  • 4.2. Global Live Cell Imaging Market, By Product
  • 4.3. Live Cell Imaging Market, By Application and Region
  • 4.4. Live Cell Imaging Microscopes Market, By Type
  • 4.5. Regional Snapshot

5. Market Overview

  • 5.1. Introduction
  • 5.2. Market Segmentation
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
      • 5.3.1.1. Adoption of High-Content Screening Techniques in Drug Discovery
      • 5.3.1.2. Rising Incidence of Cancer
      • 5.3.1.3. Government Funding for Cell-Based Research
    • 5.3.2. Restraints
      • 5.3.2.1. High Cost of High-Content Screening Systems
      • 5.3.2.2. Shortage of Skilled Professionals
    • 5.3.3. Challenge
      • 5.3.3.1. Maintaining Cell Viability & Cellular Environment in the Culture
    • 5.3.4. Opportunities
      • 5.3.4.1. Asian Market Presents High-Growth Opportunities
      • 5.3.4.2. Adoption of HCS for Primary Screening
      • 5.3.4.3. Application of Live Cell Imaging Techniques in Personalized Medicine

6. Industry Trends

  • 6.1. End-User Market Potential Analysis
    • 6.1.1. Academic and Government Institutes
    • 6.1.2. Pharmaceutical and Biotechnology Companies
    • 6.1.3. Contract Research Organizations (CRO)
    • 6.1.4. Diagnostic Laboratories
  • 6.2. Supply Chain Analysis
    • 6.2.1. Prominent Companies
    • 6.2.2. Small and Medium Enterprises
    • 6.2.3. End Users
    • 6.2.4. Key Influencers

7. Market Potential Analysis

  • 7.1. Introduction
  • 7.2. Unmet Needs/Limiting Factors
  • 7.3. Winning Imperatives to Boost the Adoption of Live Cell Imaging Techniques

8. Live Cell Imaging Market, By Product

  • 8.1. Introduction
  • 8.2. Instruments
    • 8.2.1. Standalone Systems
    • 8.2.2. Microscopes
      • 8.2.2.1. Conventional Microscopes
      • 8.2.2.2. Confocal Microscopes
      • 8.2.2.3. Advanced Fluorescence Microscopes
    • 8.2.3. Cell Analyzers
    • 8.2.4. Image Capturing Devices
  • 8.3. Consumables
    • 8.3.1. Assay Kits
    • 8.3.2. Reagents
    • 8.3.3. Media
    • 8.3.4. Other Consumables
  • 8.4. Software

9. Live Cell Imaging Market, By Technology

  • 9.1. Introduction
  • 9.2. Fluorescence Resonance Energy Transfer (FRET)
  • 9.3. Fluorescence in Situ Hybridization (FISH)
  • 9.4. High-Content Screening (HCS)
  • 9.5. Fluorescence Recovery After Photobleaching (FRAP)
  • 9.6. Ratiometric Imaging
  • 9.7. Total Internal Reflection Fluorescence Microscopy (TRIF)
  • 9.8. Multiphoton Excitation Microscopy (MPE)
  • 9.9. Other Technologies

10. Live Cell Imaging Market, By Application

  • 10.1. Introduction
  • 10.2. Cell Biology
  • 10.3. Stem Cells
  • 10.4. Developmental Biology
  • 10.5. Drug Discovery

11. Live Cell Imaging Market, By Region

  • 11.1. Introduction
  • 11.2. North America
    • 11.2.1. U.S.
      • 11.2.1.1. Increasing Incidence of Cancer to Propel the Live Cell Imaging Market in the U.S.
      • 11.2.1.2. Growth in Pharmaceutical & Biotechnology Industries in the U.S. to Drive the Market
      • 11.2.1.3. High-Content Screening (HCS) Conferences in the U.S.
    • 11.2.2. Canada
      • 11.2.2.1. Increasing Investments By the Canadian Government on Regenerative Medicine to Spur Market Growth
      • 11.2.2.2. Drug Discovery Research in Canada to Boost Market Growth
  • 11.3. Europe
    • 11.3.1.1. Increasing Government Funding in Europe to Drive the Market
    • 11.3.2. U.K.
      • 11.3.2.1. Conferences on Live Cell Imaging to Propel Market Growth
    • 11.3.3. Germany
      • 11.3.3.1. Advancements in Biotechnology Likely to Fuel the Live Cell Imaging Market in Germany
    • 11.3.4. France
      • 11.3.4.1. Advancements in the Biotechnology Sector in France
    • 11.3.5. Rest of Europe (RoE)
      • 11.3.5.1. Increasing Research on Regenerative Medicine in Spain to Drive the Market
  • 11.4. Asia
    • 11.4.1. India
      • 11.4.1.1. Growing Pharmaceutical Industry to Spur the Market in India
    • 11.4.2. China
      • 11.4.2.1. Rising Burden of Cancer in China
      • 11.4.2.2. Developing Pharmaceutical Industry in China
      • 11.4.2.3. Increasing Government Investment in the Life Sciences Sector in China
      • 11.4.2.4. Conferences on Live Cell Imaging in China
    • 11.4.3. Japan
      • 11.4.3.1. Growing Focus on Stem Cell Research in Japan
      • 11.4.3.2. Regenerative Medicine, and Biomedical and Medical Research Set to Trigger Growth of the Live Cell Imaging Market
    • 11.4.4. Rest of Asia (RoA)
      • 11.4.4.1. Increasing Government Support for Strong Academic and Commercial R&D Activities in Taiwan
    • 11.4.5. Rest of the World (RoW)
      • 11.4.5.1. Flourishing Biotechnology and Pharmaceutical Markets in Brazil
      • 11.4.5.2. Significant Developments in the Pharmaceutical Market in Africa

12. Competitive Landscape

  • 12.1. Market Share Analysis
    • 12.1.1. Introduction
    • 12.1.2. Carl Zeiss AG
    • 12.1.3. Nikon Corporation
    • 12.1.4. Leica Microsystems (Acquired By Danaher Corporation)
  • 12.2. Competitive Situation and Trends
    • 12.2.1. Introduction
    • 12.2.2. New Product Launches
    • 12.2.3. Agreements/Partnerships/Collaborations
    • 12.2.4. Expansions
    • 12.2.5. Acquisitions
    • 12.2.6. Others

13. Company Profiles

  • 13.1. Introduction
  • 13.2. Becton, Dickinson and Company
    • 13.2.1. Business Overview
    • 13.2.2. Product & Services
    • 13.2.3. Key Strategy
    • 13.2.4. Recent Developments
  • 13.3. Carl Zeiss AG
    • 13.3.1. Business Overview
    • 13.3.2. Products and Services
    • 13.3.3. Key Strategy
    • 13.3.4. Recent Developments
  • 13.4. Danaher Corporation (Leica Microsystems)
    • 13.4.1. Business Overview
    • 13.4.2. Product Portfolio
    • 13.4.3. Key Strategy
    • 13.4.4. Recent Developments
  • 13.5. GE Healthcare (Subsidiary of General Electric Company)
    • 13.5.1. Business Overview
    • 13.5.2. Product Portfolio
    • 13.5.3. Key Strategy
    • 13.5.4. Recent Developments
  • 13.6. Molecular Devices, LLC
    • 13.6.1. Business Overview
    • 13.6.2. Product Portfolio
    • 13.6.3. Key Strategy
    • 13.6.4. Recent Developments
  • 13.7. Nikon Corporation
    • 13.7.1. Business Overview
    • 13.7.2. Product Portfolio
    • 13.7.3. Key Strategy
    • 13.7.4. Recent Developments
  • 13.8. Olympus Corporation
    • 13.8.1. Business Overview
    • 13.8.2. Product Portfolio
    • 13.8.3. Key Strategy
    • 13.8.4. Recent Developments
  • 13.9. Perkinelmer, Inc.
    • 13.9.1. Business Overview
    • 13.9.2. Products and Services
    • 13.9.3. Key Strategy
    • 13.9.4. Recent Developments
  • 13.10. Sigma-Aldrich Corporation
    • 13.10.1. Business Overview
    • 13.10.2. Product Portfolio
    • 13.10.3. Key Strategy
    • 13.10.4. Recent Developments
  • 13.11. Thermo Fisher Scientific, Inc.
    • 13.11.1. Business Overview
    • 13.11.2. Product Portfolio
    • 13.11.3. Key Strategy
    • 13.11.4. Recent Developments

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. Company Developments (2012-2015)
    • 14.2.1. Carl Zeiss AG
    • 14.2.2. Danaher Corporation (2012-2014)
    • 14.2.3. Nikon Corporation (2012-2014)
    • 14.2.4. Perkinelmer, Inc. (2012)
    • 14.2.5. Sigma-Aldrich Corporation (2012-2014)
    • 14.2.6. Thermo Fisher Scientific, Inc. (2012-2014)
  • 14.3. Introducing RT: Real-Time Market Intelligence
  • 14.4. Available Customizations
  • 14.5. Related Reports

List of Tables

  • Table 1: Increasing Government Funding in Cell-Based Research Propelling the Growth of the Global Market
  • Table 2: High Cost of High-Content Screening Systems Restraining the Growth of the Market
  • Table 3: Maintaining Cell Viability and Cellular Environment is A Major Challenge in This Market
  • Table 4: Asia to Offer Significant Growth Opportunities for the Market
  • Table 5: Live Cell Imaging Products Market Size, By Region, 2012-2019 ($Million)
  • Table 6: Market Size, By Product, 2012-2019 ($Million)
  • Table 7: Live Cell Imaging Instruments Market Size, By Region, 2012-2019 ($Million)
  • Table 8: Market Size, By Instrument, 2012-2019 ($Million)
  • Table 9: Live Cell Imaging Standalone Systems Market Size, By Region, 2012-2019 ($Million)
  • Table 10: Live Cell Imaging Microscopy Market Size, By Region, 2012-2019 ($Million)
  • Table 11: Live Cell Imaging Microscopy Market Size, By Type, 2012-2019 ($Million)
  • Table 12: Live Cell Imaging Conventional Microscopy Market Size, By Region, 2012-2019 ($Million)
  • Table 13: Live Cell Imaging Confocal Microscopy Market Size, By Region, 2012-2019 ($Million)
  • Table 14: Live Cell Imaging Advanced Fluorescence Microscopy Market Size, By Region, 2012-2019 ($Million)
  • Table 15: Live Cell Imaging Cell Analyzers Market Size, By Region, 2012-2019 ($Million)
  • Table 16: Live Cell Imaging Image Capturing Devices Market Size, By Region, 2012-2019 ($Million)
  • Table 17: Live Cell Imaging Consumables Market Size, By Region, 2012-2019 ($Million)
  • Table 18: Market Size, By Consumable, 2012-2019 ($Million)
  • Table 19: Live Cell Imaging Assay Kits Market Size, By Region, 2012-2019 ($Million)
  • Table 20: Live Cell Imaging Reagents Market Size, By Region, 2012-2019 ($Million)
  • Table 21: Live Cell Imaging Media Market Size, By Region, 2012-2019 ($Million)
  • Table 22: Live Cell Imaging Other Consumables Market Size, By Region, 2012-2019 ($Million)
  • Table 23: Live Cell Imaging Software Market Size, By Region, 2012-2019 ($Million)
  • Table 24: Live Cell Imaging Market Size, By Region, 2012-2019 ($Million)
  • Table 25: Market, By Technology, 2012-2019 ($Million)
  • Table 26: Market Size for Fluorescence Resonance Energy Transfer (FRET), By Region, 2012-2019 ($Million)
  • Table 27: Market Size for Fluorescence in Situ Hybridization, By Region, 2012-2019 ($Million)
  • Table 28: Market Size for High-Content Screening, By Region, 2012-2019 ($Million)
  • Table 29: Market Size for Fluorescence Recovery After Photobleaching (HCS), By Region, 2012-2019 ($Million)
  • Table 30: Market Size for Ratiometric Imaging, By Region, 2012-2019 ($Million)
  • Table 31: Market Size for Total Internal Reflection Fluorescence Microscopy (TRIF), By Region, 2012-2019 ($Million)
  • Table 32: Market Size for Multiphoton Excitation Microscopy (MPE), By Region, 2012-2019 ($Million)
  • Table 33: Market Size for Other Technologies, By Region, 2012-2019 ($Million)
  • Table 34: Market Segmentation, By Application
  • Table 35: Live Cell Imaging Applications Market Size, By Region, 2012-2019 ($Million)
  • Table 36: Market, By Application, 2012-2019($Million)
  • Table 37: Market Size for Cell Biology, By Region, 2012-2019 ($Million)
  • Table 38: Market Size for Stem Cells, By Region, 2012-2019 ($Million)
  • Table 39: Market Size for Developmental Biology, By Region, 2012-2019 ($Million)
  • Table 40: Market Size for Drug Discovery, By Region, 2014-2019 ($Million)
  • Table 41: Live Cell Imaging Market Size, By Region, 2012-2019 ($Million)
  • Table 42: North America: Market Size, By Country, 2012-2019 ($Million)
  • Table 43: North America: Market Size, By Product, 2012-2019 ($Million)
  • Table 44: North America: Market Size, By Instruments, 2012-2019 ($Million)
  • Table 45: North America: Live Cell Imaging Microscopy Market Size, By Type, 2012-2019 ($Million)
  • Table 46: North America: Market Size, By Consumable, 2012-2019 ($Million)
  • Table 47: North America: Market Size, By Technology, 2012-2019 ($Million)
  • Table 48: North America: Market Size, By Application, 2012-2019 ($Million)
  • Table 49: U.S.: Market Size, By Product, 2012-2019 ($Million)
  • Table 50: U.S.: Market Size, By Instruments, 2012-2019 ($Million)
  • Table 51: U.S.: Live Cell Imaging Microscopy Market Size, By Type, 2012-2019 ($Million)
  • Table 52: U.S.: Market Size, By Consumable, 2012-2019 ($Million)
  • Table 53: U.S.: Market Size, By Technology, 2012-2019 ($Million)
  • Table 54: U.S.: Market Size, By Application, 2012-2019 ($Million)
  • Table 55: Canada: Market Size, By Product, 2012-2019 ($Million)
  • Table 56: Canada: Market Size, By Instruments, 2012-2019 ($Million)
  • Table 57: Canada: Live Cell Imaging Microscopy Market Size, By Type, 2012-2019 ($Million)
  • Table 58: Canada: Market Size, By Consumable, 2012-2019 ($Million)
  • Table 59: Canada: Market Size, By Technology, 2012-2019 ($Million)
  • Table 60: Canada: Market Size, By Application, 2012-2019 ($Million)
  • Table 61: Europe: Market Size, By Country, 2012-2019 ($Million)
  • Table 62: Europe: Market Size, By Product, 2012-2019 ($Million)
  • Table 63: Europe: Market Size, By Instruments, 2012-2019 ($Million)
  • Table 64: Europe: Live Cell Imaging Microscopy Market Size, By Type, 2012-2019 ($Million)
  • Table 65: Europe: Market Size, By Consumable, 2012-2019 ($Million)
  • Table 66: Europe: Market Size, By Technology, 2012-2019 ($Million)
  • Table 67: Europe: Market Size, By Application, 2012-2019 ($Million)
  • Table 68: U.K.: Market Size, By Product, 2012-2019 ($Million)
  • Table 69: U.K.: Market Size, By Instruments, 2012-2019 ($Million)
  • Table 70: U.K.: Live Cell Imaging Microscopy Market Size, By Type, 2012-2019 ($Million)
  • Table 71: U.K.: Market Size, By Consumable, 2012-2019 ($Million)
  • Table 72: U.K.: Market Size, By Technology, 2012-2019 ($Million)
  • Table 73: U.K.: Market Size, By Application, 2012-2019 ($Million)
  • Table 74: Germany: Market Size, By Product, 2012-2019 ($Million)
  • Table 75: Germany: Market Size, By Instruments, 2012-2019 ($Million)
  • Table 76: Germany: Live Cell Imaging Microscopy Market Size, By Type, 2012-2019 ($Million)
  • Table 77: Germany: Market Size, By Consumable, 2012-2019 ($Million)
  • Table 78: Germany: Market Size, By Technology, 2012-2019 ($Million)
  • Table 79: Germany: Market Size, By Application, 2012-2019 ($Million)
  • Table 80: France: Market Size, By Product, 2012-2019 ($Million)
  • Table 81: France: Market Size, By Instruments, 2012-2019 ($Million)
  • Table 82: France: Live Cell Imaging Microscopy Market Size, By Type, 2012-2019 ($Million)
  • Table 83: France: Market Size, By Consumable, 2012-2019 ($Million)
  • Table 84: France: Market Size, By Technology, 2012-2019 ($Million)
  • Table 85: France: Market Size, By Application, 2012-2019 ($Million)
  • Table 86: RoE: Market Size, By Product, 2012-2019 ($Million)
  • Table 87: RoE: Market Size, By Instruments, 2012-2019 ($Million)
  • Table 88: RoE: Live Cell Imaging Microscopy Market Size, By Type, 2012-2019 ($Million)
  • Table 89: RoE: Market Size, By Consumable, 2012-2019 ($Million)
  • Table 90: RoE: Market Size, By Technology, 2012-2019 ($Million)
  • Table 91: RoE: Market Size, By Application, 2012-2019 ($Million)
  • Table 92: Asia: Market Size, By Country, 2012-2019 ($Million)
  • Table 93: Asia: Market Size, By Product, 2012-2019 ($Million)
  • Table 94: Asia: Market Size, By Instruments, 2012-2019 ($Million)
  • Table 95: Asia: Live Cell Imaging Microscopy Market Size, By Type, 2012-2019 ($Million)
  • Table 96: Asia: Market Size, By Consumable, 2012-2019 ($Million)
  • Table 97: Asia: Market Size, By Technology, 2012-2019 ($Million)
  • Table 98: Asia: Market Size, By Application, 2012-2019 ($Million)
  • Table 99: India: Market, By Product, 2012-2019 ($Million)
  • Table 100: India: Market, By Instruments, 2012-2019 ($Million)
  • Table 101: India: Live Cell Imaging Microscopy Market Size, By Type, 2012-2019 ($Million)
  • Table 102: India: Market Size, By Consumable, 2012-2019 ($Million)
  • Table 103: India: Market Size, By Technology, 2012-2019 ($Million)
  • Table 104: India: Market Size, By Application, 2012-2019 ($Million)
  • Table 105: China: Market Size, By Product, 2012-2019 ($Million)
  • Table 106: China: Market Size, By Instruments, 2012-2019 ($Million)
  • Table 107: China: Live Cell Imaging Microscopy Market Size, By Type, 2012-2019 ($Million)
  • Table 108: China: Market Size, By Consumable, 2012-2019 ($Million)
  • Table 109: China: Market Size, By Technology, 2012-2019 ($Million)
  • Table 110: China: Market Size, By Application, 2012-2019 ($Million)
  • Table 111: Japan: Market Size, By Product, 2012-2019 ($Million)
  • Table 112: Japan: Market Size, By Instruments, 2012-2019 ($Million)
  • Table 113: Japan: Live Cell Imaging Microscopy Market Size, By Type, 2012-2019 ($Million)
  • Table 114: Japan: Market Size, By Consumable, 2012-2019 ($Million)
  • Table 115: Japan: Market Size, By Technology, 2012-2019 ($Million)
  • Table 116: Japan: Market Size, By Application, 2012-2019 ($Million)
  • Table 117: RoA: Market Size, By Product, 2012-2019 ($Million)
  • Table 118: RoA: Market Size, By Instruments, 2012-2019 ($Million)
  • Table 119: RoA: Live Cell Imaging Microscopy Market Size, By Type, 2012-2019 ($Million)
  • Table 120: RoA: Market Size, By Consumable, 2012-2019 ($Million)
  • Table 121: RoA: Market Size, By Technology, 2012-2019 ($Million)
  • Table 122: RoA: Market Size, By Application, 2012-2019 ($Million)
  • Table 123: RoW: Market Size, By Product, 2012-2019 ($Million)
  • Table 124: RoW: Market Size, By Instruments, 2012-2019 ($Million)
  • Table 125: RoW: Live Cell Imaging Microscopy Market Size, By Type, 2012-2019 ($Million)
  • Table 126: RoW: Market Size, By Consumable, 2012-2019 ($Million)
  • Table 127: RoW: Market Size, By Technology, 2012-2019 ($Million)
  • Table 128: RoW: Market Size, By Application, 2012-2019 ($Million)

List of Figures

  • Figure 1: Live Cell Imaging Market
  • Figure 2: Research Methodology
  • Figure 3: Sampling Frame: Primary Research
  • Figure 4: Breakdown of Primary Interviews: By Company Type, Designation, and Region
  • Figure 5: Market Size Estimation Methodology: Bottom-Up Approach
  • Figure 6: Market Size Estimation Methodology: Top-Down Approach
  • Figure 7: Market Forecast Methodology
  • Figure 8: Data Triangulation Methodology
  • Figure 9: Consumables Segment to Grow at the Highest Rate in the Forecast Period
  • Figure 10: Microscopes Segment Continues to Dominate the Market
  • Figure 11: Conventional Microscopes Held Largest Share of the Live Cell Imaging Microscopy Market
  • Figure 12: Assay Kits Dominate the Live Cell Imaging Consumables Market
  • Figure 13: Fluorescence Resonance Energy Transfer (FRET) Dominated Market, By Technology, in 2014
  • Figure 14: Stem Cells Application Likely to Grow at the Fastest Rate
  • Figure 15: Asia to Show the Highest Growth Rate From 2014 to 2019
  • Figure 16: Market Overview
  • Figure 17: Consumables to Witness Highest Growth Rate During the Forecast Period
  • Figure 18: North America Dominated the Market in 2014
  • Figure 19: Confocal Microscopes Segment to Grow at the Highest Rate in the Forecast Period
  • Figure 20: Asia to Witness Highest Growth Rate During the Forecast Period
  • Figure 21: Market: Drivers, Restraints, Challenges, & Opportunities
  • Figure 22: Academic & Government Institutes, the Most Lucrative Market Segment
  • Figure 23: Supply Chain Analysis:
  • Figure 24: Limiting Factors
  • Figure 25: End-User Expectations
  • Figure 26: Global Market, By Product
  • Figure 27: Asia to Grow at the Highest CAGR of 11.1% in the Forecast Period
  • Figure 28: Consumables Segment to Grow at the Highest CAGR of 9.5%
  • Figure 29: Confocal Microscopes Segment to Grow at the Highest CAGR of 10% During the Forecast Period
  • Figure 30: Asia to Show Highest Growth During the Forecast Period 2014-2019
  • Figure 31: Fluorescence Resonance Energy Transfer (FRET) Technology Segment to Grow at Highest CAGR of 9.8%
  • Figure 32: Asia to Grow at the Highest CAGR of 11.1% in the Forecast Period
  • Figure 33: Stem Cells Segment to Grow at the Highest CAGR of 9.4% During the Forecast Period
  • Figure 34: North American Market to Grow at the Highest CAGR in the Forecast Period
  • Figure 35: North America Accounted for the Largest Share of the Market (2014)
  • Figure 36: Germany to Be the Fastest Growing Market for Live Cell Imaging in Europe
  • Figure 37: China to Be the Fastest Growing Market for Live Cell Imaging in India
  • Figure 38: Rest of the World (RoW) Expected to Grow at A CAGR of 6.1% During 2014 to 2019
  • Figure 39: Market Share Analysis, By Key Player, 2014
  • Figure 40: Strategies Adopted By Key Players Over the Last Three Years
  • Figure 41: Battle for Market Share: New Product Launch Was the Key Strategy
  • Figure 42: New Product Launches, 2012-2015
  • Figure 43: Agreements/Partnerships/Collaborations, 2012-2015
  • Figure 44: Expansion, 2012-2015
  • Figure 45: Acquisition, 2012-2015
  • Figure 46: Other Strategies, 2012-2015
  • Figure 47: Geographical Revenue of Top Players
  • Figure 48: Becton, Dickinson and Company: Company Snapshot
  • Figure 49: Carl Zeiss AG: Company Snapshot
  • Figure 50: Danaher Corporation (Leica Microsystems): Company Snapshot
  • Figure 51: GE Healthcare: Company Snapshot
  • Figure 52: Molecular Devices, LLC: Company Snapshot
  • Figure 53: Nikon Corporation: Company Snapshot
  • Figure 54: Olympus Corporation: Company Snapshot
  • Figure 55: Perkinelmer, Inc.: Company Snapshot
  • Figure 56: Sigma-Aldrich Corporation: Company Snapshot
  • Figure 57: Thermo Fisher Scientific, Inc.: Company Snapshot
Back to Top